Trevi Therapeutics, Inc. (TRVI)
Pharmaceutical Preparations
Latest Price
$15.04
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
2.13
P/B Ratio
7.07
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 13.22M | $246.0M | 9.28% | -- | 2026-06-30 |
| FMR LLC | 12.56M | $234.0M | 8.82% | +4.52M | 2026-06-30 |
| BlackRock, Inc. | 11.16M | $208.0M | 7.83% | +914.8K | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 9.94M | $185.0M | 6.98% | -100 | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 5.68M | $106.0M | 3.99% | +495.5K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.53M | $103.0M | 3.88% | +552.1K | 2026-06-30 |
| Vivo Capital, LLC | 5.09M | $95.0M | 3.58% | -- | 2026-06-30 |
| Woodline Partners LP | 4.08M | $76.0M | 2.87% | +3.08M | 2026-06-30 |
| Vestal Point Capital, LP | 3.10M | $57.0M | 2.18% | +933.5K | 2026-06-30 |
| MPM BIOIMPACT LLC | 3.07M | $57.0M | 2.16% | -224.9K | 2026-06-30 |